Nov 1 (Reuters) - Discovery Laboratories Inc:
* Labs' kl4 surfactant granted orphan drug designation for the treatment of
cystic fibrosis
* Says is also in the process of applying for orphan designation for cf
treatment in Europe
((Bangalore Equities Newsroom; +91 80 4135 5800; within U.S. +1 646 223 8780))
(For more news, please click here) COPYRIGHT Copyright Thomson Reuters 2010. All rights reserved. The copying, republication or redistribution of Reuters News Content, including by framing or similar means, is expressly prohibited without the prior written consent of Thomson Reuters.
* Labs' kl4 surfactant granted orphan drug designation for the treatment of
cystic fibrosis
* Says is also in the process of applying for orphan designation for cf
treatment in Europe
((Bangalore Equities Newsroom; +91 80 4135 5800; within U.S. +1 646 223 8780))
(For more news, please click here) COPYRIGHT Copyright Thomson Reuters 2010. All rights reserved. The copying, republication or redistribution of Reuters News Content, including by framing or similar means, is expressly prohibited without the prior written consent of Thomson Reuters.
© 2010 AFX News
